Skip to main content

Animations

MJFF Publications

6681 - 6690 of 8813 Results
Title
Year
  • Year
  • 2010
  • 2020
  • 2021
  • 2023
  • 2017
  • 2024
  • 2025
  • 2016
  • 2019
  • 2017
  • Summary Details
    RESTRICTED
    Title: Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22792
    Citation Count: 74
  • Summary Details
    RESTRICTED
    Title: The role of disease duration and severity on novel clinical subtypes of Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.013
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18443
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients
    Journal Name: Toxicology Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Mapping the human brain proteome: opportunities, challenges, and clinical potential
    Journal Name: Expert Review of Proteomics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14789450.2024.2313073
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping review
    Journal Name: Pharmacological Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pharmr.2025.100094
    Citation Count: 0
  • Summary Details
    OPEN
    Title: PREFACE: Divergent roles of ER stress in neurodegeneration and brain disorders
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.brainres.2016.09.014
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Sacral nerve stimulation improves gait in Parkinson's disease
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.03.074
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.013
    Citation Count: 33
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.